ResMed Inc (RME.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:33PM CEST
| Previous close | 172.45 |
| Open | 189.45 |
| Bid | 202.70 x 30000 |
| Ask | 203.70 x 30000 |
| Day's range | 187.50 - 202.30 |
| 52-week range | 126.90 - 219.00 |
| Volume | |
| Avg. volume | 27 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GuruFocus.comDecoding ResMed Inc (RMD): A Strategic SWOT Insight
Insightful Analysis of ResMed Inc's Financial Health and Strategic Position
Investor's Business DailyHow 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
ZacksInteger Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
© 2024 Yahoo. All rights reserved.